Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: additional insights
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1364-8535
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: additional insights ; volume:23 ; number:1 ; day:12 ; month:12 ; year:2019 ; pages:1-2 ; date:12.2019
Critical care ; 23, Heft 1 (12.12.2019), 1-2, 12.2019
- Creator
-
Honore, Patrick M.
Mugisha, Aude
Barreto Gutierrez, Leonel
Redant, Sebastien
Kaefer, Keitiane
Gallerani, Andrea
Bels, David De
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13054-019-2692-2
- URN
-
urn:nbn:de:101:1-2020041310321967955253
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:57 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Honore, Patrick M.
- Mugisha, Aude
- Barreto Gutierrez, Leonel
- Redant, Sebastien
- Kaefer, Keitiane
- Gallerani, Andrea
- Bels, David De
- SpringerLink (Online service)
Other Objects (12)
Oxidative stress markers and septic acute kidney injury: Novel research avenue or road to nowhere?
Passive leg raising test with minimally invasive monitoring: the way forward for guiding septic shock resuscitation?
Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: some nuances
Optimizing ceftolozane-tazobactam dosage in critically ill patients during continuous venovenous hemodiafiltration
Potential confounders in linking elevated S100A8/A9 to left ventricular dysfunction in septic shock patients
Beneficial effects of antioxidant therapy in crush syndrome in a rodent model: enough evidences to be used in humans?
Renal protection in sepsis: Is hypertonic sodium (lactate) the solution?
CytoSorb removes MDMA in vitro, but is it an effective therapy in vivo?
VCO2 calorimetry: stop tossing stones, it’s time for building!
Normal saline as resuscitation fluid in critically ill patients: not dead yet!
Is an EAA > 0.6 in severe COVID-19 patients synonymous with a toxic and pro-inflammatory endotoxin profile, and should we treat it?
Reliability of biomarkers of sepsis during extracorporeal therapies: the clinician needs to know what is eliminated and what is not
Oxidative stress markers and septic acute kidney injury: Novel research avenue or road to nowhere?
Passive leg raising test with minimally invasive monitoring: the way forward for guiding septic shock resuscitation?
Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: some nuances
Optimizing ceftolozane-tazobactam dosage in critically ill patients during continuous venovenous hemodiafiltration
Potential confounders in linking elevated S100A8/A9 to left ventricular dysfunction in septic shock patients
Beneficial effects of antioxidant therapy in crush syndrome in a rodent model: enough evidences to be used in humans?
Renal protection in sepsis: Is hypertonic sodium (lactate) the solution?
CytoSorb removes MDMA in vitro, but is it an effective therapy in vivo?
VCO2 calorimetry: stop tossing stones, it’s time for building!
Normal saline as resuscitation fluid in critically ill patients: not dead yet!
Is an EAA > 0.6 in severe COVID-19 patients synonymous with a toxic and pro-inflammatory endotoxin profile, and should we treat it?
Reliability of biomarkers of sepsis during extracorporeal therapies: the clinician needs to know what is eliminated and what is not
Oxidative stress markers and septic acute kidney injury: Novel research avenue or road to nowhere?
Passive leg raising test with minimally invasive monitoring: the way forward for guiding septic shock resuscitation?
Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: some nuances
Optimizing ceftolozane-tazobactam dosage in critically ill patients during continuous venovenous hemodiafiltration
Potential confounders in linking elevated S100A8/A9 to left ventricular dysfunction in septic shock patients
Beneficial effects of antioxidant therapy in crush syndrome in a rodent model: enough evidences to be used in humans?
Renal protection in sepsis: Is hypertonic sodium (lactate) the solution?
CytoSorb removes MDMA in vitro, but is it an effective therapy in vivo?
VCO2 calorimetry: stop tossing stones, it’s time for building!
Normal saline as resuscitation fluid in critically ill patients: not dead yet!
Is an EAA > 0.6 in severe COVID-19 patients synonymous with a toxic and pro-inflammatory endotoxin profile, and should we treat it?